Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Cleantech Invest portfolio firm Enersize closes deal for installation at Scania Södertälje plant

Enersize has entered into an agreement to install their system for measuring and analyzing industrial compressed air systems in Scania´s Södertälje factory.  Enersize has now signed 7 new contracts of their system for measuring, analyzing and optimising compressed air whereof 6 in China this year.   Cleantech Invest CEO Alexander Lidgren comments: ”Installations in bigger factories on European soil is important for Enersize and to install the new software at a reference customer like Scania  is the best possible start of European market growth.”  Cleantech Invest owns 37.7% of

GARO to acquire WEB-EL Försäljning AB

GARO has acquired WEB-EL Försäljning AB (“WEB-EL”) on 27 October 2017. WEB-EL develops and sells systems and electronic components for controlling sockets for charging stations, engine heaters, camp sites and marinas. WEB-EL’s sales in the fiscal year from 1 July 2016 – 30 June 2017 amounted to MSEK 7.5 with an EBIT of MSEK 3.0. The company’s operations started in 2004 in Luleå, Sweden, and the company’s founders will remain in the business following the takeover. The purchase consideration is MSEK 17.7 on a debt-free basis, including an amount of a maximum of MSEK 2.9 which is paid

Vps34 strengthens the immuno-oncology field

Previous research has shown that tumors use autophagy to escape the body's immune system. Sprint Bioscience has shown that inhibition of autophagy with the company's substance SB02024 activates the immune system in the tumor.With the new information, Sprint Bioscience is now presenting the Vps34 project as an immuno-oncology project. Immuno-oncology is a new field in cancer drug treatment, where the patient's own immune cells fights the tumor. Sprint Bioscience participates in the BIO-Europe Partner Conference in Berlin 6-8 November. During the planned meetings with representatives from

Interim report January to September 2017

Press release, Stockholm, Sweden, 27 October 2017 Continued profitable growth Third quarter · Net sales increased during the third quarter by 57,2% to 45,0 MSEK (28,6) · Result before depreciation (EBITDA) increased during the third quarter by 135,3% to 4,0 MSEK (1,7), corresponding to a margin of 9,0% (6,0) · Net result after tax was 2,3 MSEK (-0,1) · Result per share was 0,01 (-0,00) · Cash flow from the business for the period was 4,3 MSEK (1,0) January - September · Net sales increased during the period by 86,2% to 137,5 MSEK (73,8) · Result before

C-RAD AB – Interim report January-September 2017

Key events in the period July - September 2017 THIRD QUARTER 2017                                                    ·       Order intake: 55.5 (28.2) MSEK, +97%.o    Elekta, New Karolinska Hospital, Sweden: 21 MSEKo    University Medical Center Freiburg, Germany: 7,8 MSEK·       Revenues: 33.2 (22.5) MSEK, +48%.·       EBITDA: -0.3 (-6.4) MSEK.·       Operating loss: -1.4 (-7.9) MSEK.·       Result per share -0.05 (-0.29) SEK.·       Positive operating cash flow 10,0 (-13,9) MSEK  Comments from Tim Thurn, CEO:   In the third quarter we continued to grow

Polygon strengthens its position as the leading property damage control company in Germany

Polygon has signed an agreement to acquire the company Von der Lieck GmbH & Co (VDL) in Germany. The acquisition will add 25 employees and annual sales of EUR 4 million.“We are very happy to have reached an agreement with VDL. I have known the company for several years as a strong and respected competitor to Polygon. The company has a very solid market position in western Germany and I am pleased that they are now part of our team. I would like to take this opportunity to welcome our new employees to the Polygon family. Together I am convinced that we will become even stronger and continue

Interim Report January– September 2017

Highlights from the third quarter                  · Sales increased by 1 percent in local currencies. Reported sales declined by 1 percent to 4,069 MSEK (4,118) for the third quarter. · Operating profit from product areas in local currencies increased by 2 percent. Reported operating profit from product areas1) amounted to 1,089 MSEK (1,089) for the third quarter. · Operating profit amounted to 1,089 MSEK (2,694) for the third quarter. The previous year’s third quarter included larger one-time items of 1,550 MSEK relating to a capital gain from the partial divestment of STG and an

Heliospectra AB (publ) Interim Management Statement January – September 2017

”…more than 120% growth compared to the same quarter last year.” (GOTHENBURG, Sweden/SAN FRANCISCO, CA, October 27th, 2017) – Heliospectra AB (publ) (OTCQB: HLSPY, FIRSTNORTH: HELIO), a world leader in intelligent lighting technology for controlled environments horticulture, presents today their Interim Management Statement for January - September 2017.Turnover and profit/loss January - September · Net sales amounted to 19,550 (16,189) KSEK· Operating profit/loss amounted to -25,611 (-30,316) KSEK· Profit/loss after tax was -25,701 (-30,409) KSEK or -0,73 (-1,63) SEK per share [

Electrolux President and CEO Jonas Samuelson’s comments on the results for the third quarter 2017

Earnings improvement for the Group continuesIn the third quarter Electrolux continued to deliver earnings improvement, achieving an operating margin of 6.7%. Profitability increased across our business areas with four business areas reaching an operating margin above 7%. The favorable earnings trend was supported by product mix improvements and accelerated cost efficiency despite organic sales decline, mainly related to North America. In EMEA, the positive product mix development continued and our premium brands gained market share. Operating income improved and the margin increased to 7.

Interim Report - 6 months 1 April-30 September 2017

Second quarter (1 July-30 September 2017) · Revenue increased by 7 percent to MSEK 1,293 (1,210). · Operating profit rose by 29 percent to MSEK 62 (48). Adjusted operating profit (excluding items affecting comparability) totalled MSEK 63 (48), corresponding to an adjusted operating margin of 4.9 percent (4.0). · The return on working capital (P/WC) for the most recent 12-month period was 21 percent (21). · Net profit increased by 34 percent to MSEK 47 (35). · Earnings per share rose by 32 percent to SEK 1.65 (1.25). · The operational net loan liability amounted to MSEK

Acando Interim Report January 1–September 30, 2017

Third quarter, July 1–September 30, 2017 · Net sales totaled SEK 518 m (469) · Operating profit amounted to SEK 27 m (33) · The operating margin was 5.2% (7.0) · Profit after tax was SEK 17 m (28) · Earnings per share were SEK 0.17 (0.27) Accumulated, January 1–September 30, 2017 · Net sales totaled SEK 1,753 m (1,573) · Operating profit amounted to SEK 157 m (128) · The operating margin was 8.9% (8.2) · Profit after tax was SEK 113 m (113) · Earnings per share were SEK 1.09 (1.09) · Cash, cash equivalents totaled SEK 59 m (68)Statement by Carl-Magnus

Alma Media’s Interim Report January–September 2017: Strong profitability growth in the third quarter

Alma Media Corporation               Interim Report                      27 October 2017 at 9:00 a.m. (EEST) Alma Media’s Interim Report January–September 2017: STRONG PROFITABILITY GROWTH IN THE THIRD QUARTER Financial performance July–September 2017:  · Revenue MEUR 86.0 (80.9), up 6.3%. · Adjusted operating profit MEUR 14.0 (9.1), or 16.2% (11.2%) of revenue, up 52.7%. · Operating profit MEUR 14.3 (8.9), or 16.6% (11.0%) of revenue, up 60.2%. · Earnings per share were EUR 0.12 (0.07). · Alma Markets: Strong and profitable growth continued with the support of the

REPORT FOR THE THIRD QUARTER 2017

Financial and operating highlights 3Q 2017 (3Q 2016 in brackets): · Operating revenues were NOK 2 180 million (NOK 3 346 million)  · EBITDA (operating result before depreciation, impairment, result from associates, finance and tax) was NOK 572 million (NOK 1 343 million) · Year on year EBITDA improvement of NOK 23 million, apart from Offshore drilling · EBIT (operating result) was NOK - 96 million (NOK 38 million · Net finance was NOK - 208 million (NOK - 230 million) · Net result after tax was NOK - 338 million (NOK - 251 million) Offshore

Lux Helsinki to feature light installations also during the morning

Photo: Lauri Rotko Light festival wins Helsinki Travel Award and will light up the city again from 6–10 January 2018. The Helsinki Tourism Foundation announced yesterday that Lux Helsinki has won the Helsinki Travel Award, which is presented annually in October to distinguished parties or events that have had a positive impact on the tourism industry, its reputation or customer satisfaction. The Helsinki Tourism Foundation praised the light festival for its innovative artistic implementation: “As an annual light festival that takes place among the streets, market squares and

Interim Report January - September

Continued strong and profitable growth without signs of slowdownJULY–SEPTEMBER 2017 · Income amounted to SEK 1,271 million (802), an increase of 58 percent · Operating profit amounted to SEK 67 million (65) and the operating margin was 5.3 percent (8.1) · Net profit amounted to SEK 51 million (52) · Earnings per share after dilution amounted to SEK 2.18 (2.95) · Operating income for the contracting operations amounted to SEK 45 million (12) and operating margin to 3.6 percent (1.5) · Cash flow from operating activities amounted to SEK 84 million (negative 59) · Order

Hexagon Interim Report 1 January - 30 September 2017

Third quarter 2017 • Operating net sales increased by 10 per cent to 859.7 MEUR (779.7). Using fixed exchange rates and a comparable group structure (organic growth), net sales increased by 6 per cent • Operating earnings (EBIT1) increased by 15 per cent to 205.9 MEUR (179.8) • Earnings before taxes, excluding non-recurring items, amounted to 200.3 MEUR (174.2) • Net earnings, excluding non-recurring items, amounted to 164.2 MEUR (141.1) • Earnings per share, excluding non-recurring items, increased by 15 per cent to 0.45 EUR (0.39) • Operating cash flow improved by 32 per

Interim Report July–September 2017

Third Quarter 9 Months · Revenue · Revenue increased by 17.2% to €427.5m (€364.8m). Organicincreased by revenue grew by 15.0%.16.0% to · Net profit amounted to €11.0m (€4.8m), which represents a€144.0m net profit margin of 2.6% (1.3%).(€124.1m). · EBITDA increased by 22.4% to €40.4m (€33.0m), correspondingOrganic to an EBITDA margin of 9.5% (9.0%). Excluding IPO costsrevenue grew expensed, EBITDA increased by 27.9% to €42.2m a margin of 9.9%.by 13.2%. · Number of members increased by 18.2% reaching 1 million · Operating

XVIVO Perfusion (publ) Interim Report January – September 2017

CONTINUED GROWTH AND PROGRESS IN THREE DEVELOPMENT PROJECTSTHIRD QUARTER 2017 (JUL - SEP) · Net sales of non-durable goods in the quarter amounted to SEK 31.6 (29.1) million, corresponding to an increase of 8 percent in SEK. Sales of non-durable goods increased by 11 percent in local currency. Net sales in the quarter amounted to SEK 32.3 (31.7) million, corresponding to an increase of 2 percent. The increase corresponds to 4 percent in local currency.   · Operating income before depreciation and amortization (EBITDA), excluding items affecting comparability, amounted to SEK 4.4 (5.

Interim Report July – September 2017: Continued strong demand for highly upgraded climate efficient iron ore products

Demand for LKAB’s highly upgraded climate efficient iron ore products in the global market remains strong. The positive price trend resulted in strong earnings and cash flow for the third quarter.Operating profit for the third quarter was MSEK 1,813 (273) and net sales amounted to MSEK 5,990 (4,258). Profits and sales were positively impacted by a higher iron ore price and a higher pellet premium when comparing with the same period last year. The average price level for the global spot price of iron ore was USD 71/tonne for the quarter, compared with USD 59/tonne for the same period last

Obducat enters into financing agreement with Blue Ocean

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN OR CANADA OR ANY OTHER JURISDICTION WHERE PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. THIS PRESSRELEASE DOES NOT CONSTITUTE AN OFFER OF ANY SECURITIES OF OBDUCAT. Obducat AB (publ) (“Obducat” or the “Company”) has entered into an agreement with Blue Ocean Investment Group’s (“Blue Ocean”) investment vehicle European High Growth Opportunities Securitization Fund regarding a financing solution based on issuance of convertible bonds and warrants.

Bactiguard wins another tender in Sweden

Bactiguard has won a tender for urinary catheters for the Västra Götaland region (VGR) in Sweden, which enables healthcare providers in both primary and secondary care and 49 municipalities in the region to purchase Bactiguards’ urinary catheters for infection prevention. The contract is valid for 2 years and can be extended for another 2 years.“We are very pleased that VGR has also included infection prevention in their procured assortment, by adding our urinary catheter. Earlier this year, we have signed agreements with Stockholm County Council, Skåne region and the County Council in

Caverion Corporation’s Interim Report for January 1 – September 30, 2017

Caverion Corporation Interim Report October 27, 2017 at 9.00 a.m. EESTCaverion Corporation’s Interim Report for January 1 – September 30, 2017  First signs of improved performance July 1 – September 30, 2017  · Order backlog: EUR 1,460.4 (1,450.9) million · Revenue: EUR 545.1 (582.0) million · EBITDA excluding restructuring costs: EUR 13.8 (19.5) million, or 2.5 (3.3) percent of revenue · EBITDA: EUR 8.7 (13.8) million, or 1.6 (2.4) percent of revenue · Working capital: EUR 75.7 (56.1) million · Free cash flow: EUR -43.8 (-38.8) million · Earnings per share,

There are no items matching the current filter
There are no more items matching the current filter
Back to top